(4-(1-(4-Methylpiperazin-1-yl) ethyl)phenyl)boronic acid
98%
- Product Code: 89218
CAS:
1704069-65-7
| Molecular Weight: | 248.129 g./mol | Molecular Formula: | C₁₃H₂₁BN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of pharmaceuticals. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of complex molecules, including potential drug candidates. The presence of the 4-methylpiperazine moiety enhances its utility in designing compounds with improved pharmacokinetic properties, such as solubility and bioavailability. It is often explored in the creation of targeted therapies, particularly in oncology, where boronic acid derivatives are known for their role in proteasome inhibition. Additionally, its structural features make it a candidate for research in neurological and inflammatory diseases, where modulation of specific biological pathways is required.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $1,654.05 |
+
-
|
(4-(1-(4-Methylpiperazin-1-yl) ethyl)phenyl)boronic acid
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of pharmaceuticals. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of complex molecules, including potential drug candidates. The presence of the 4-methylpiperazine moiety enhances its utility in designing compounds with improved pharmacokinetic properties, such as solubility and bioavailability. It is often explored in the creation of targeted therapies, particularly in oncology, where boronic acid derivatives are known for their role in proteasome inhibition. Additionally, its structural features make it a candidate for research in neurological and inflammatory diseases, where modulation of specific biological pathways is required.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :